Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine

25 Dec 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers in Disease Mechanisms
Share to Pancreatic and Hepatic Oncology Research
Share to S100 Proteins and Annexins

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33359364
DOI: 10.1016/j.bcp.2020.114396

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabinePMID 33359364Read ↗

Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.Semantic proximity Read ↗

Epigenetics of epithelial‐to‐mesenchymal transition in pancreatic carcinomaSemantic proximity Read ↗

S100 Proteins in Pancreatic Cancer: Current Knowledge and Future PerspectivesSemantic proximity Read ↗

The Role of S100A9 in the Interaction Between Pancreatic Ductal Adenocarcinoma Cells and Stromal CellsSemantic proximity Read ↗

Epithelial and Mesenchymal Features of Pancreatic Ductal Adenocarcinoma Cell Lines in Two- and Three-Dimensional CulturesSemantic proximity Read ↗

FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expressionSemantic proximity Read ↗

Expression of S100P and Its Novel Binding Partner S100PBPR in Early Pancreatic CancerSemantic proximity Read ↗

Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.Semantic proximity Read ↗

Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.Semantic proximity Read ↗

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancerSemantic proximity Read ↗

Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic TargetSemantic proximity Read ↗

TRIM37 promoted the growth and migration of the pancreatic cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.